USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Jane Street Group LLC

Jane Street Group LLC grew its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 330.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,979 shares of the company’s stock after buying an additional 30,681 shares during the period. Jane Street Group LLC owned 0.21% of USANA Health Sciences worth $1,435,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Northern Trust Corp grew its holdings in shares of USANA Health Sciences by 16.5% during the fourth quarter. Northern Trust Corp now owns 135,937 shares of the company’s stock worth $4,879,000 after purchasing an additional 19,266 shares during the last quarter. Tudor Investment Corp ET AL acquired a new stake in shares of USANA Health Sciences in the 4th quarter valued at about $341,000. Aquatic Capital Management LLC grew its stake in USANA Health Sciences by 220.7% during the 4th quarter. Aquatic Capital Management LLC now owns 11,865 shares of the company’s stock worth $426,000 after buying an additional 8,165 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in USANA Health Sciences by 15.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,234 shares of the company’s stock worth $260,000 after buying an additional 985 shares during the period. Finally, Dark Forest Capital Management LP purchased a new stake in USANA Health Sciences in the fourth quarter valued at approximately $619,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Trading Down 0.7%

Shares of USNA stock opened at $30.07 on Tuesday. The company has a market capitalization of $559.99 million, a P/E ratio of 10.63, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60. The business’s 50 day moving average is $27.03 and its two-hundred day moving average is $32.35. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $49.78.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.03. The firm had revenue of $249.54 million for the quarter, compared to analyst estimates of $243.08 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period last year, the firm posted $0.86 EPS. As a group, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,234 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $32.98, for a total value of $106,657.32. Following the completion of the sale, the insider now owns 12,775 shares of the company’s stock, valued at approximately $421,319.50. This trade represents a 20.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Joshua Foukas sold 5,732 shares of the business’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,142 shares of company stock valued at $655,050. 0.63% of the stock is owned by corporate insiders.

Analyst Ratings Changes

USNA has been the topic of a number of research reports. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. DA Davidson dropped their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. Finally, Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.